Answers are grounded in this paper and cite their sources.
Metabolic dysfunction-associated steatohepatitis (MASH) involves persistent hepatic inflammation in which CD8 + T cells exhibit diverse functional states. Clonal expansion and autoaggressive cytotoxicity have emerged as important features of this response, yet their relationship remains unresolved. Studies of human MASH-associated cirrhosis and experimental models support antigen-associated clonal expansion, whereas functional studies demonstrate that local cytokines and metabolites can enable hepatocyte killing independently of cognate antigen recognition. This mini review examines these complementary findings and evaluates whether clonality and autoaggression arise within shared or partly distinct CD8 + T cell populations. We discuss IL-15-dependent regulation of FOXO1 and CXCR6, together with acetate and extracellular ATP–P2X7 signaling, as mechanisms linking the hepatic microenvironment to pathological effector activity. Clonal enrichment is distinguished from demonstrated antigen specificity and pathogenic function, with attention to disease stage, target cell identity, and the limitations of human and experimental evidence. The ability of selected CD8 + T cell populations to promote fibrosis resolution further underscores the importance of tissue context. Therapeutic opportunities therefore center on restraining harmful activation while preserving protective immunity and tissue repair. Integrating paired T cell receptor and transcriptional profiling with functional validation may clarify the connection between clonal expansion and autoaggression and inform selective immunomodulation in MASH.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: